May 22, 2014Anavex Reports That New Data Confirms Calcium Target Over-Expression May Be Involved in Causing AD
Mar 31, 2014Anavex Encouraged by Scientific Data; Sigma-1 Receptor Agonist is Potentially Disease-Modifying
Mar 31, 2014Anavex Strengthens Alzheimer's Pipeline, Obtains Exclusive Worldwide Rights to Intellectual Property
Mar 26, 2014A novel multipotent sigma 1/M1 muscarinic activator for a comprehensive therapeutic strategy in AD